Form 4: Jennifer A. Doudna Reports Acquisition of Deferred Share Units in Johnson & Johnson

Sentiment:

SEC Form 4 Filing


Director Jennifer A. Doudna reports the acquisition of 1,316 Deferred Share Units (DSUs) in Johnson & Johnson on April 24, 2025, under the company's Amended and Restated Deferred Fee Plan for Directors.

Summary

  • On April 24, 2025, Jennifer A. Doudna, a director of Johnson & Johnson, acquired 1,316 Deferred Share Units (DSUs) under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
  • These DSUs will be settled in cash upon termination of Doudna's directorship, with each DSU representing the fair market value of one share of Johnson & Johnson Common Stock on the settlement date.
  • Following the reported transaction, Doudna beneficially owns 9,656.1384 derivative securities, which includes dividend equivalent rights accrued on the DSUs.
  • The reported transaction was filed on April 28, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and insider alignment with company performance.

Positives

  • The acquisition of Deferred Share Units aligns the director's interests with the long-term performance of Johnson & Johnson.
  • The Deferred Fee Plan for Directors allows for deferred compensation, potentially offering tax advantages.

Future Outlook

The Deferred Share Units will be settled in cash upon termination of the Reporting Person's directorship.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

  • Deferred compensation plans for directors are common among large publicly traded companies like Johnson & Johnson.
  • Companies such as Pfizer (PFE) and Merck (MRK) also utilize similar deferred compensation structures for their board members.
  • These plans are designed to align director compensation with long-term shareholder value, similar to practices observed at other blue-chip companies like Procter & Gamble (PG) and Coca-Cola (KO).

Stakeholder Impact

  • The acquisition of DSUs by a director signals confidence in the company's future performance to shareholders.
  • The compensation structure aligns the director's interests with those of the shareholders.

Key Dates

DateDescription
04/24/2025Date of transaction: Jennifer A. Doudna acquired 1,316 Deferred Share Units.
04/28/2025Date of filing: The Form 4 was filed on this date.

Keywords

Deferred Share Units, DSU, Director, Jennifer A. Doudna, Johnson & Johnson, JNJ, Form 4, Beneficial Ownership, Securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.